Concepedia
Statistics
Publications
7
Citations
728
H-Index
Active since
2005
Affiliations
Janssen (Belgium)(Current)
Johnson & Johnson (United States)
An N. Hermans is an author at Janssen (Belgium) specializing in medicine, pharmacology, and risk assessment.
Top concepts
MedicinePharmacologyCardiologyPhysiologyAntibioticsDrug ResistancePharmacotherapyRisk AssessmentElectrophysiologyInfection Control
Publications per year
2005–2018
Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity
Elisa Passini, Oliver J. Britton, Hua Rong Lu et al. · Frontiers in Physiology · 2017 · 316 citations · Full text
Predicting drug‐induced changes in QT interval and arrhythmias: QT‐shortening drugs point to gaps in the ICHS7B Guidelines
Hua Rong Lu, Eddy Vlaminckx, An N. Hermans et al. · British Journal of Pharmacology · 2008 · 130 citations · Full text
In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome
David J. Gallacher, A VANDEWATER, H VANDERLINDE et al. · Cardiovascular Research · 2007 · 113 citations
In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation
Hua Rong Lu, Eddy Vlaminckx, A. Van de Water et al. · European Journal of Pharmacology · 2006 · 62 citations
Risk Assessment, Antimicrobial Susceptibility, Antibiotics +11
Does terfenadine‐induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
Hua Rong Lu, An N. Hermans, David J. Gallacher · British Journal of Pharmacology · 2012 · 47 citations · Full text
Rows per page
1–5 of 7